Mark Mallon, Anthony Rodgers, the George Medicines team, and Brandon Capital investors, Stephen Thompson and Melissa Byrne
All products / Type / Easy Pen KLOW (KPV, GHK-Cu, TB-500, and BPC-157) 80mg Easy pen Four-Peptide Blend (KPV, GHK-Cu, BPC-157, TB-500) Tissue-Repair, Skin & Inflammation Research Easy PenRecovery & RepairSkin, Hair & BeautyImmunity & Gut SKU: EP-KL-80-4 99.9% Purity $295 Format Easy Pen Dosage 0.26 mg combined per click Capacity 80mg Potential benefits Multi-peptide research blend Inflammation modulation Tissue-repair research Collagen & skin research Recovery-support research Multi-pathway repair research KLOW is an advanced peptide formulation designed to support tissue regeneration, inflammation control, and skin repair
These treatments were originally designed to treat type-2 diabetes because they also help your body produce more insulin and regulate blood sugar
I., Patel, K., Brdak, A., Heffernan, J., & Ahmad, N
Its collaboration with biotech company Neumora (for neurometabolic diseases) may yield new metabolic treatments